Barrett’s esophagus is a condition where the normal lining of the lower esophagus is replaced by tissue that resembles the lining of the intestine. About 1% of the general population has it, though many never know. It develops most often in people with long-standing acid reflux, and while it raises the risk of a specific type of esophageal cancer, that progression is rare for most people.
How the Esophagus Changes
Your esophagus is normally lined with flat, layered cells called squamous epithelium. In Barrett’s esophagus, chronic exposure to stomach acid and bile damages those cells, and they’re gradually replaced by taller, column-shaped cells that look more like what you’d find in your intestine. This swap is called intestinal metaplasia, and the hallmark is the appearance of goblet cells, a type of mucus-producing cell that belongs in the gut, not the esophagus.
The leading theory is that stem cells in the esophagus, responding to ongoing acid injury, begin differentiating into this intestinal-type tissue instead of regenerating the original lining. There are several proposed sources for these stem cells: the base layer of the esophageal lining itself, cells at the junction where the esophagus meets the stomach, or even stem cells from esophageal glands deeper in the tissue. The replacement doesn’t happen overnight. It typically requires years of repeated damage.
Who Is Most at Risk
Chronic acid reflux (GERD) is the most well-known trigger, but the full picture is more nuanced. Among people with GERD, roughly 5 to 7% develop Barrett’s esophagus. Add another risk factor on top of GERD, and prevalence jumps to about 12%. A family history of Barrett’s or esophageal cancer carries the highest prevalence of all, around 23%.
Several factors meaningfully increase risk:
- Sex: Men are about twice as likely as women to develop Barrett’s (odds ratio of 2.13).
- Central obesity: Carrying excess weight around the midsection roughly doubles the odds (odds ratio of 2.04).
- Tobacco use: Smoking raises risk by about 40%.
- Age: Risk climbs steadily after 50. Prevalence in people over 50 is around 6%.
One notable finding: alcohol consumption does not appear to increase the risk of Barrett’s esophagus or the esophageal cancer associated with it.
Symptoms You Might Notice
Barrett’s esophagus itself doesn’t produce symptoms. What you feel are the symptoms of the underlying acid reflux that caused it: frequent heartburn, regurgitation of stomach contents, difficulty swallowing, and occasionally chest pain. These are GERD symptoms, not Barrett’s-specific ones.
Here’s the catch: roughly half of people diagnosed with Barrett’s report little to no reflux symptoms at all. This “silent reflux” means acid is still damaging the esophagus, but without the typical burning sensation. That’s why Barrett’s is sometimes discovered incidentally during an endoscopy done for unrelated reasons, or missed entirely in people who never had a reason to get scoped.
How It’s Diagnosed
Diagnosis requires two things: visual confirmation during an upper endoscopy and a biopsy showing the characteristic intestinal-type cells under a microscope. During the endoscopy, the doctor looks for salmon-colored tissue extending upward from where the esophagus meets the stomach, replacing the normal pale pink lining.
Doctors grade the extent of the change using a standardized system called the Prague C & M criteria, which measures how far the abnormal tissue wraps around the esophagus (circumferential extent) and how far up it reaches at its longest point (maximal extent). This system is highly reliable for segments 1 cm or longer. Shorter segments are harder to assess consistently, which is one reason very short patches of Barrett’s can be tricky to diagnose.
The Cancer Question
Barrett’s esophagus is considered a precancerous condition because it can, in some cases, progress to esophageal adenocarcinoma. That said, the actual risk is low. A large population-based study of over 8,500 patients found that those with Barrett’s and no dysplasia (no precancerous cellular changes) had an annual cancer risk of just 0.10%, or about 1 in 1,000 per year. Even when combining cancer and high-grade precancerous changes, the annual rate was only 0.17%.
Progression follows a stepwise path. Normal Barrett’s tissue can develop low-grade dysplasia, then high-grade dysplasia, then cancer. Most people with Barrett’s never progress past the first stage. In the study above, 95% of patients had no dysplasia at all at the time of their initial biopsy.
Surveillance Schedules
Because of the small but real cancer risk, people with Barrett’s esophagus are placed on a surveillance program of periodic endoscopies with biopsies. How often you go back depends on what the biopsies show.
- No dysplasia: Repeat endoscopy every 3 years.
- Indefinite for dysplasia (cells look abnormal but not clearly precancerous): Annual endoscopy until the findings change.
- Confirmed low-grade dysplasia: Endoscopy every 6 months for the first year, then annually. The initial finding should be confirmed by a repeat exam with an expert endoscopist within 6 months.
These intervals are designed to catch changes early, when they’re most treatable. For most people, surveillance endoscopies are straightforward outpatient procedures done with sedation.
Treatment and Management
The foundation of Barrett’s management is controlling acid reflux. Proton pump inhibitors (PPIs), the same class of medication used for severe heartburn, are the standard treatment. These drugs suppress stomach acid production, which protects the esophageal lining from further damage and allows some healing. In one study, two years of high-dose PPI therapy reduced the length of Barrett’s tissue, and 25% of patients developed small islands of normal squamous tissue regrowing within the Barrett’s segment.
PPIs won’t eliminate Barrett’s, but they help control the environment that caused it and may slow or prevent progression.
Ablation for Precancerous Changes
When biopsies show dysplasia, particularly high-grade dysplasia, treatment becomes more aggressive. Radiofrequency ablation (RFA) uses controlled heat energy delivered through an endoscope to destroy the abnormal tissue. A systematic review and meta-analysis found that RFA successfully eliminated all precancerous changes in 91% of patients and eliminated all intestinal-type tissue in 78%. After successful treatment, about 13% of patients had some recurrence of intestinal metaplasia during follow-up, which is why continued surveillance remains important even after ablation.
For visible nodules or raised areas within the Barrett’s segment, doctors can remove the abnormal tissue during an endoscopy (a procedure called endoscopic mucosal resection) before or alongside ablation. These are all done through the mouth with an endoscope, with no external incisions.
Diet and Lifestyle Changes
Managing Barrett’s esophagus day to day means managing the acid reflux behind it. Several dietary and lifestyle adjustments can make a real difference in symptom control and may reduce ongoing esophageal irritation.
Foods and drinks commonly linked to reflux flare-ups include citrus fruits, tomatoes, chocolate, coffee, high-fat foods, mint, and spicy foods. Alcohol can also trigger symptoms. You don’t necessarily need to eliminate all of these, but paying attention to which ones worsen your reflux and cutting back on those is practical advice.
Timing matters too. Eating your last meal at least 3 hours before lying down can significantly reduce nighttime reflux. If you carry extra weight, especially around the midsection, losing weight can lower both reflux severity and Barrett’s risk. Elevating the head of your bed by 6 to 8 inches (using blocks under the bedframe, not just extra pillows) helps gravity keep stomach contents where they belong overnight.